Moderna, Inc. Increase (Decrease) in Other Operating Liabilities
Moderna, Inc. (MRNA) reported Increase (Decrease) in Other Operating Liabilities of -$27.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-07-31
- Moderna, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$53.00M.
- Moderna, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $26.00M, a 21.21% decline year-over-year.
- Moderna, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $131.00M, a 7.09% decline year-over-year.
- Moderna, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$112.00M, a 2900.00% decline year-over-year.
- Moderna, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$6.00M, a 107.69% decline from fiscal 2024.
- Moderna, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was $78.00M, a 11.36% decline from fiscal 2023.
- Moderna, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was $88.00M.
- Moderna, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$740.00M, a 701.63% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$27.00M 10-Q · filed 2026-07-31 | $104.00M derived: sum of 3 quarters · filed 2026-07-31 | -$8.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2026-03-31 | $26.00M 10-Q · filed 2026-05-01 | $157.00M derived: sum of 2 quarters · filed 2026-05-01 | $45.00M derived: sum of 3 quarters · filed 2026-05-01 | -$13.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-12-31 | $131.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $19.00M derived: sum of 2 quarters · filed 2026-02-20 | -$39.00M derived: sum of 3 quarters · filed 2026-07-31 | -$6.00M 10-K · filed 2026-02-20 | ||||
| 2025-09-30 | -$112.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$170.00M derived: sum of 2 quarters · filed 2026-07-31 | -$137.00M 10-Q · filed 2025-11-06 | $4.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-06-30 | -$58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$25.00M 10-Q · filed 2026-07-31 | $116.00M derived: sum of 3 quarters · filed 2026-07-31 | $120.00M derived: sum of 4 quarters · filed 2026-07-31 | ||||
| 2025-03-31 | $33.00M 10-Q · filed 2026-05-01 | $174.00M derived: sum of 2 quarters · filed 2026-05-01 | $178.00M derived: sum of 3 quarters · filed 2026-05-01 | -$8.00M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $141.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $145.00M derived: sum of 2 quarters · filed 2026-02-20 | -$41.00M derived: sum of 3 quarters · filed 2026-02-20 | $78.00M 10-K · filed 2026-02-20 | ||||
| 2024-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$182.00M derived: sum of 2 quarters · filed 2025-11-06 | -$63.00M 10-Q · filed 2025-11-06 | -$5.00M 10-Q · filed 2024-11-07 | $4.00M derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2024-06-30 | -$186.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$67.00M 10-Q · filed 2025-08-01 | -$11.00M 10-Q · filed 2024-08-01 | $0.00 derived: sum of 3 quarters · filed 2026-02-20 | $39.00M derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2024-03-31 | $119.00M 10-Q · filed 2025-05-01 | $130.00M 10-Q · filed 2024-05-02 | $186.00M derived: sum of 2 quarters · filed 2026-02-20 | $225.00M derived: sum of 3 quarters · filed 2026-02-20 | $222.00M derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2023-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $106.00M derived: sum of 2 quarters · filed 2026-02-20 | $103.00M derived: sum of 3 quarters · filed 2026-02-20 | $88.00M 10-K · filed 2026-02-20 | $73.00M 10-K · filed 2024-02-23 | |||
| 2023-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $36.00M derived: sum of 2 quarters · filed 2024-11-07 | $21.00M 10-Q · filed 2024-11-07 | -$992.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$18.00M 10-Q · filed 2024-08-01 | -$1.03B derived: sum of 3 quarters · filed 2025-02-21 | -$1.02B derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2023-03-31 | -$15.00M 10-Q · filed 2024-05-02 | -$1.03B derived: sum of 2 quarters · filed 2025-02-21 | -$1.02B derived: sum of 3 quarters · filed 2025-02-21 | -$790.00M derived: sum of 4 quarters · filed 2025-02-21 | ||||
| 2022-12-31 | -$1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$1.00B derived: sum of 2 quarters · filed 2025-02-21 | -$775.00M derived: sum of 3 quarters · filed 2025-02-21 | -$740.00M 10-K · filed 2025-02-21 | $88.00M 10-K · filed 2023-02-24 | |||
| 2022-09-30 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $238.00M derived: sum of 2 quarters · filed 2023-11-03 | $273.00M 10-Q · filed 2023-11-03 | $373.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $228.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $263.00M 10-Q · filed 2023-08-03 | $363.00M derived: sum of 3 quarters · filed 2024-02-23 | $323.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $35.00M 10-Q · filed 2023-05-04 | $135.00M derived: sum of 2 quarters · filed 2024-02-23 | $95.00M derived: sum of 3 quarters · filed 2024-02-23 | $155.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $100.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $60.00M derived: sum of 2 quarters · filed 2024-02-23 | $120.00M derived: sum of 3 quarters · filed 2024-02-23 | $123.00M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | -$40.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $20.00M derived: sum of 2 quarters · filed 2022-11-03 | $23.00M 10-Q · filed 2022-11-03 | $24.00M derived: sum of 4 quarters · filed 2023-02-24 | ||||
| 2021-06-30 | $60.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $63.00M 10-Q · filed 2022-08-03 | $440.00M 10-Q · filed 2021-08-05 | $64.00M derived: sum of 3 quarters · filed 2023-02-24 | $67.00M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2021-03-31 | $3.00M 10-Q · filed 2022-05-04 | $93.00M 10-Q · filed 2021-05-06 | $4.00M derived: sum of 2 quarters · filed 2023-02-24 | $7.00M derived: sum of 3 quarters · filed 2023-02-24 | $5.00M derived: sum of 4 quarters · filed 2023-02-24 | |||
| 2020-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $4.00M derived: sum of 2 quarters · filed 2023-02-24 | $2.00M derived: sum of 3 quarters · filed 2023-02-24 | $8.00M 10-K · filed 2023-02-24 | $5.99M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $1.00M derived: sum of 2 quarters · filed 2021-11-04 | $7.00M 10-Q · filed 2021-11-04 | $6.68M 10-Q · filed 2020-10-30 | $1.15M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $4.00M 10-Q · filed 2021-08-05 | $4.41M 10-Q · filed 2020-08-06 | -$1.85M derived: sum of 3 quarters · filed 2022-02-25 | -$2.67M derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2020-03-31 | $6.00M 10-Q · filed 2021-05-06 | $5.73M 10-Q · filed 2020-05-07 | $153.00K derived: sum of 2 quarters · filed 2022-02-25 | -$674.00K derived: sum of 3 quarters · filed 2022-02-25 | -$811.00K derived: sum of 4 quarters · filed 2022-02-25 | |||
| 2019-12-31 | -$5.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$6.67M derived: sum of 2 quarters · filed 2022-02-25 | -$6.81M derived: sum of 3 quarters · filed 2022-02-25 | -$6.00M 10-K · filed 2022-02-25 | -$6.17M 10-K · filed 2020-02-27 | |||
| 2019-09-30 | -$827.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | -$964.00K derived: sum of 2 quarters · filed 2020-10-30 | -$153.00K 10-Q · filed 2020-10-30 | $1.62M 10-Q · filed 2019-11-06 | -$97.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-06-30 | -$137.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $674.00K 10-Q · filed 2020-08-06 | $53.00K 10-Q · filed 2019-08-08 | $730.00K derived: sum of 3 quarters · filed 2021-02-26 | $792.00K derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2019-03-31 | $811.00K 10-Q · filed 2020-05-07 | $484.00K 10-Q · filed 2019-05-09 | $867.00K derived: sum of 2 quarters · filed 2021-02-26 | $929.00K derived: sum of 3 quarters · filed 2021-02-26 | $1.54M derived: sum of 4 quarters · filed 2021-02-26 | |||
| 2018-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $118.00K derived: sum of 2 quarters · filed 2021-02-26 | $727.00K derived: sum of 3 quarters · filed 2021-02-26 | $910.00K 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $671.00K derived: sum of 2 quarters · filed 2019-11-06 | $854.00K 10-Q · filed 2019-11-06 | |||||
| 2018-06-30 | $609.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $792.00K 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | $183.00K 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | -$145.00K 10-K · filed 2020-02-27 | |||||||
| 2016-12-31 | $1.98M 10-K · filed 2019-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |